Novozymes A/S B
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more
Novozymes A/S B (NVZMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.030x
Based on the latest financial reports, Novozymes A/S B (NVZMF) has a cash flow conversion efficiency ratio of 0.030x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($320.10 Million) by net assets ($10.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novozymes A/S B - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Novozymes A/S B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Novozymes A/S B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novozymes A/S B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bunge Global SA
LSE:0ADJ
|
N/A |
|
Aristocrat Leisure Limited
PINK:ARLUF
|
0.268x |
|
BOE Technology Group Co Ltd
SHE:000725
|
0.070x |
|
IVBIY
PINK:IVBIY
|
N/A |
|
China Overseas Land Investment
PINK:CAOVY
|
-0.001x |
|
Ashtead Group plc
PINK:ASHTF
|
0.086x |
|
Novozymes AS
PINK:NVZMY
|
0.043x |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
0.165x |
Annual Cash Flow Conversion Efficiency for Novozymes A/S B (2002–2024)
The table below shows the annual cash flow conversion efficiency of Novozymes A/S B from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $11.18 Billion | $1.02 Billion | 0.091x | -68.46% |
| 2023-12-31 | $14.35 Billion | $4.15 Billion | 0.289x | +2.76% |
| 2022-12-31 | $14.23 Billion | $4.01 Billion | 0.282x | -15.39% |
| 2021-12-31 | $12.21 Billion | $4.06 Billion | 0.333x | -14.08% |
| 2020-12-31 | $11.24 Billion | $4.36 Billion | 0.387x | +39.12% |
| 2019-12-31 | $11.48 Billion | $3.20 Billion | 0.278x | -13.45% |
| 2018-12-31 | $11.44 Billion | $3.68 Billion | 0.322x | -10.80% |
| 2017-12-31 | $11.27 Billion | $4.06 Billion | 0.361x | +10.30% |
| 2016-12-31 | $11.74 Billion | $3.84 Billion | 0.327x | +13.52% |
| 2015-12-31 | $11.59 Billion | $3.34 Billion | 0.288x | -28.20% |
| 2014-12-31 | $11.28 Billion | $4.53 Billion | 0.401x | +70.80% |
| 2013-12-31 | $11.07 Billion | $2.60 Billion | 0.235x | -18.52% |
| 2012-12-31 | $9.57 Billion | $2.76 Billion | 0.288x | -6.11% |
| 2011-12-31 | $8.82 Billion | $2.71 Billion | 0.307x | +3.51% |
| 2010-12-31 | $7.84 Billion | $2.32 Billion | 0.297x | -4.50% |
| 2009-12-31 | $5.85 Billion | $1.82 Billion | 0.311x | -18.09% |
| 2008-12-31 | $4.48 Billion | $1.70 Billion | 0.379x | -18.89% |
| 2007-12-31 | $3.67 Billion | $1.71 Billion | 0.467x | +3.39% |
| 2006-12-31 | $3.39 Billion | $1.53 Billion | 0.452x | +29.36% |
| 2005-12-31 | $3.79 Billion | $1.33 Billion | 0.349x | +5.69% |
| 2004-12-31 | $3.89 Billion | $1.29 Billion | 0.331x | +0.48% |
| 2003-12-31 | $4.17 Billion | $1.37 Billion | 0.329x | +18.38% |
| 2002-12-31 | $4.25 Billion | $1.18 Billion | 0.278x | -- |